MBRX_Logo.png
Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast
March 19, 2025 08:05 ET | Moleculin Biotech, Inc.
HOUSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates...
Logo_Pharming_original.png
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
March 13, 2025 02:00 ET | Pharming Group N.V.
Full year 2024 total revenues increased by 21% to US$297.2 million and exceeded our guidance, driven by record RUCONEST® revenue and strong Joenja® (leniolisib) growth Fourth quarter 2024 total...
Optinose_logo_RGB.png
Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025 16:15 ET | Optinose, Inc.
YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
March 06, 2025 07:30 ET | MacroGenics, Inc.
ROCKVILLE, MD, March 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
BWEN Logo.png
Broadwind Announces Fourth Quarter and Full-Year 2024 Results
March 05, 2025 07:00 ET | Broadwind, Inc.
CICERO, Ill., March 05, 2025 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and solutions serving global markets,...
BeautyHealth_InLine.png
BeautyHealth to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
March 04, 2025 16:05 ET | The Beauty Health Company
The Beauty Health Company will report fourth quarter and full year 2024 financial results after market close on Wednesday, March 12, 2025.
Logo_Pharming_original.png
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
February 27, 2025 02:00 ET | Pharming Group N.V.
Leiden, the Netherlands, February 27, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year...
MYR Group logo
MYR Group Inc. Announces Fourth Quarter and Full Year 2024 Results
February 26, 2025 16:07 ET | MYR Group, Inc.
THORNTON, Colo., Feb. 26, 2025 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR” or the "Company") (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility...
Hillman_logo.jpg
Hillman to Present at the Raymond James 46th Annual Institutional Investors Conference
February 26, 2025 07:30 ET | The Hillman Group
CINCINNATI, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, announced its...
micron-logo-black (1).png
Micron Technology to Report Fiscal Second Quarter Results on March 20, 2025
February 20, 2025 16:01 ET | Micron Technology, Inc.
BOISE, Idaho, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) announced today that it will hold its fiscal second quarter earnings conference call on Thursday, Mar. 20, 2025,...